08/14/2025
9:58 AM | JANUS HENDERSON GROUP PLC (Filed by)
Monopar Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
08/12/2025
7:00 AM | Monopar Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/12/2025
7:01 AM | Monopar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/16/2025
8:02 PM | Monopar Therapeutics (Issuer)
Robinson Chandler (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/16/2025
8:03 PM | Monopar Therapeutics (Issuer)
STARR CHRISTOPHER M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/16/2025
8:06 PM | Monopar Therapeutics (Issuer)
Tsuchimoto Kim R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/14/2025
11:26 AM | Monopar Therapeutics (Subject)
Tsuchimoto Kim R (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/14/2025
11:29 AM | Monopar Therapeutics (Subject)
STARR CHRISTOPHER M (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/14/2025
11:21 AM | Monopar Therapeutics (Subject)
Robinson Chandler (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/14/2025
10:59 AM | JANUS HENDERSON GROUP PLC (Filed by)
Monopar Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
05/13/2025
7:00 AM | Monopar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for MNPR and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Monopar Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
05/13/2025
7:00 AM | Monopar Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/07/2025
5:00 AM | Monopar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/30/2025
2:34 PM | Monopar Therapeutics (Filer)
| Form DEF 14A | |
04/04/2025
6:27 PM | Brown Michael J (Reporting)
Mazar Andrew Paul (Reporting)
Monopar Therapeutics (Issuer)
O'Halloran Thomas V. (Reporting)
Robinson Chandler (Reporting)
Tactic Pharma LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2025
8:08 PM | Cittadine Andrew (Reporting)
Monopar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2025
8:07 PM | Monopar Therapeutics (Issuer)
Robinson Chandler (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2025
10:45 AM | Monopar Therapeutics (Subject)
Tactic Pharma LLC (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/31/2025
7:00 AM | Monopar Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/31/2025
7:04 AM | Monopar Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/31/2025
7:04 AM | Monopar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/07/2025
8:24 PM | Monopar Therapeutics (Issuer)
Robinson Chandler (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
8:09 PM | Cittadine Andrew (Reporting)
Monopar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
7:14 PM | Monopar Therapeutics (Issuer)
STARR CHRISTOPHER M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
6:48 PM | Monopar Therapeutics (Issuer)
Tsuchimoto Kim R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
6:51 PM | Monopar Therapeutics (Issuer)
Talukdar Lavina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
6:55 PM | Anderson Raymond (Reporting)
Monopar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
6:58 PM | KLAUSNER ARTHUR J (Reporting)
Monopar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2025
6:07 PM | Monopar Therapeutics (Issuer)
Talukdar Lavina (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/05/2025
3:06 PM | Monopar Therapeutics (Issuer)
Vu Quan Anh (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/24/2025
4:15 PM | Monopar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2025
5:25 PM | Monopar Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SCHEDULE 13G/A | |
02/12/2025
8:45 AM | Adage Capital Management, L.P. (Filed by)
Monopar Therapeutics (Subject)
| Form SCHEDULE 13G | |
02/07/2025
4:01 PM | Gem Pharmaceuticals LLC (Subject)
Monopar Therapeutics (Filed by)
| Form SCHEDULE 13D/A | |
01/27/2025
11:15 PM | Monopar Therapeutics (Filer)
| Form EFFECT | |
01/27/2025
4:19 PM | Monopar Therapeutics (Filer)
| Form 424B3 | |
01/15/2025
4:01 PM | Monopar Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
01/08/2025
10:38 AM | JANUS HENDERSON GROUP PLC (Filed by)
Monopar Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
01/02/2025
5:14 PM | Monopar Therapeutics (Issuer)
Robinson Chandler (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2025
5:15 PM | Cittadine Andrew (Reporting)
Monopar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2025
5:16 PM | Monopar Therapeutics (Issuer)
RIOUX PATRICE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
An $8 trillion-dollar discovery 17,000 ft underwater (Ad) A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materials critical for AI chips, EV batteries, smartphones, and advanced weapons systems.
While few people know about these metals, global powers—including the U.S., China, and Russia—are racing to secure them. And one tiny public company, recently backed by the U.S. government, holds mining rights to over 340 million tons… and near-monopoly access to the richest zone. See the name and ticker behind America’s $16 trillion resource push. |
12/23/2024
3:06 PM | Monopar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/23/2024
5:01 AM | Monopar Therapeutics (Filer)
| Form 424B5 | |
12/18/2024
4:01 PM | Monopar Therapeutics (Filer)
| Form 424B3 | |
12/17/2024
11:15 PM | Monopar Therapeutics (Filer)
| Form EFFECT | |
12/06/2024
7:00 AM | Monopar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/29/2024
4:01 PM | Monopar Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
11/08/2024
7:02 AM | Monopar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2024
7:01 AM | Monopar Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/06/2024
2:13 PM | JANUS HENDERSON GROUP PLC (Filed by)
Monopar Therapeutics (Subject)
| Form SC 13G | |
10/31/2024
3:17 PM | Monopar Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13G | |
10/28/2024
3:04 PM | Monopar Therapeutics (Filer)
| Form 424B5 | |
10/28/2024
5:00 AM | ASTRAZENECA PLC (Filed by)
ASTRAZENECA PLC (Filed by)
Monopar Therapeutics (Subject)
| Form SC 13G | |
10/24/2024
3:08 PM | Monopar Therapeutics (Subject)
TANG CAPITAL MANAGEMENT LLC (Filed by)
| Form SC 13G | |
10/24/2024
6:00 AM | Monopar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/22/2024
7:00 AM | Monopar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/15/2024
7:00 AM | Monopar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/07/2024
7:00 AM | Monopar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/02/2024
6:45 PM | Monopar Therapeutics (Issuer)
Robinson Chandler (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2024
6:44 PM | Cittadine Andrew (Reporting)
Monopar Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2024
7:00 AM | Monopar Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
MarketBeat All Access